Provided by Tiger Fintech (Singapore) Pte. Ltd.

Agenus

5.36
-0.1600-2.90%
Post-market: 5.700.3380+6.31%19:59 EDT
Volume:269.14K
Turnover:1.46M
Market Cap:146.95M
PE:-0.63
High:5.63
Open:5.50
Low:5.34
Close:5.52
Loading ...

Agenus (AGEN) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
11 Mar

William Blair Sticks to Its Hold Rating for Agenus (AGEN)

TIPRANKS
·
11 Mar

Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
11 Mar

Agenus: Q4 Earnings Snapshot

Associated Press Finance
·
11 Mar

Agenus Q4 2024 GAAP EPS $(2.04) Beats $(2.54) Estimate, Sales $26.84M Miss $30.27M Estimate

Benzinga
·
11 Mar

Agenus reports Q4 EPS ($2.04), consensus ($2.54)

TIPRANKS
·
11 Mar

Press Release: Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program

Dow Jones
·
11 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Mar

Agenus Inc expected to post a loss of $2.54 a share - Earnings Preview

Reuters
·
07 Mar

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
27 Feb

Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications

Business Wire
·
27 Feb

Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference

Business Wire
·
26 Feb

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

Business Wire
·
25 Feb

Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting

Business Wire
·
24 Feb

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Zacks
·
21 Feb

Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting

Business Wire
·
13 Feb

Incyte terminates license agreement with Agenus

TIPRANKS
·
11 Feb

BRIEF-Agenus Inc - Incyte To Terminate Agreement With Agenus Effective February 2026

Reuters
·
11 Feb

Agenus Regains Rights to LAG-3 and TIM-3 Programs

TIPRANKS
·
11 Feb

Agenus (AGEN) Is Attractively Priced Despite Fast-paced Momentum

Zacks
·
06 Feb